Drugs / Liquid Stored Platelets (LSP)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04631211 Comparator | Mar 2021 → Jan 2022 | bone marrow failure syndrome, myelodysplastic syndrome, myeloproliferative neoplasm, thrombocytopenia | Cellphire Therapeutics, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liquid Stored Platelets (LSP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04631211 ↗ |